Every record from Janoshik · page 60
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018433 | Tirzepatide | WWB | WWB-2411-A2303 | 2025-Q1 | 99.37 | 2.32 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021179 | BPC-157 | WXT | WXT-2408-X6472 | 2025-Q1 | 98.16 | 5.04 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019552 | KPV | Homopeptide | HOMO-2411-P1141 | 2025-Q1 | 98.92 | 5.50 | 93.3 | Laboratory-retained | 0 | FAIL |
| AX-2025-018566 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.93 | 3.38 | 91.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018477 | Tirzepatide | WWB | WWB-2502-U2990 | 2025-Q1 | 99.52 | 4.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020350 | CJC-1295 with DAC | MKM | MKM-2409-W3972 | 2025-Q1 | 99.18 | 3.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020781 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 99.25 | 6.28 | 99.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020660 | L-Glutathione (reduced) | SSA | SSA-2501-W8087 | 2025-Q1 | 99.39 | 10.83 | 96.7 | Supplier-supplied | 0 | PASS |
| AX-2025-020508 | SS-31 (Elamipretide) | KP | KP-2408-H6177 | 2025-Q1 | 99.67 | 3.72 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019267 | Afamelanotide | TFC | TFC-2502-Y6610 | 2025-Q1 | 99.01 | 4.82 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018947 | BPC-157 | FGP | FGP-2409-Y1557 | 2025-Q1 | 99.30 | 5.19 | 103.1 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018467 | Tirzepatide | WWB | WWB-2502-U2990 | 2025-Q1 | 99.14 | 3.18 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020925 | Thymalin | CPC | CPC-2501-V3057 | 2025-Q1 | N/A | 6.53 | — | Buyer-sourced | 0 | N/A |
| AX-2025-020787 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 97.91 | 7.14 | — | Buyer-sourced | 2 | FAIL |
| AX-2025-020488 | Sermorelin | KP | KP-2501-V5157 | 2025-Q1 | 98.99 | 5.51 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020461 | Liraglutide | KP | KP-2502-E5076 | 2025-Q1 | 99.33 | 6.49 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018852 | Liraglutide | QSC | QSC-2502-M9247 | 2025-Q1 | 99.55 | 3.56 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020928 | Thymalin | CPC | CPC-2501-V3057 | 2025-Q1 | N/A | 6.75 | — | Supplier-supplied | 0 | N/A |
| AX-2025-020788 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 97.95 | 6.74 | 94.1 | Laboratory-retained | 2 | FAIL |
| AX-2025-019951 | Melanotan II | SWB | SWB-2411-L5707 | 2025-Q1 | 99.65 | 7.29 | 101.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019702 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 98.16 | 3.00 | 94.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020277 | Enclomiphene citrate | MKM | MKM-2408-L2880 | 2025-Q1 | 98.11 | 4.19 | 89.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-019224 | Semaglutide | TFC | TFC-2502-L6365 | 2025-Q1 | 98.16 | 3.25 | 95.7 | Supplier-supplied | 0 | PASS |
| AX-2025-021182 | BPC-157 | WXT | WXT-2408-X6472 | 2025-Q1 | 98.59 | 4.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019506 | Humanin (HNG) | Homopeptide | HOMO-2408-A1230 | 2025-Q1 | 99.68 | 6.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019275 | Survodutide | TFC | TFC-2409-Y6260 | 2025-Q1 | 99.27 | 6.57 | 92.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-019145 | Ipamorelin | TFC | TFC-2408-T4425 | 2025-Q1 | 99.08 | 3.91 | 97.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021027 | MK-677 (Ibutamoren mesylate) | WXT | WXT-2502-F3530 | 2025-Q1 | 99.66 | 4.43 | 92.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-020533 | Melanotan II | SSA | SSA-2501-N6217 | 2025-Q1 | 98.44 | 5.26 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019409 | TB-500 | Homopeptide | HOMO-2410-E8462 | 2025-Q1 | 99.66 | 5.01 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018946 | BPC-157 | FGP | FGP-2409-Y1557 | 2025-Q1 | 99.68 | 4.41 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018814 | Kisspeptin-10 | QSC | QSC-2412-W8004 | 2025-Q1 | 99.57 | 5.47 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021043 | Sermorelin | WXT | WXT-2411-H3906 | 2025-Q1 | 97.69 | 6.43 | 89.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-020939 | Ipamorelin | CPC | CPC-2503-J2830 | 2025-Q1 | 97.86 | 6.79 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020349 | CJC-1295 with DAC | MKM | MKM-2409-W3972 | 2025-Q1 | 99.09 | 3.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020008 | Pemvidutide | ERP | ERP-2408-G6565 | 2025-Q1 | 98.42 | 5.01 | 98.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020926 | Thymalin | CPC | CPC-2501-V3057 | 2025-Q1 | N/A | 6.55 | — | Supplier-supplied | 0 | N/A |
| AX-2025-020534 | Melanotan II | SSA | SSA-2501-N6217 | 2025-Q1 | 99.11 | 5.31 | 93.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020044 | BPC-157 | ERP | ERP-2502-P7707 | 2025-Q1 | 99.93 | 3.63 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019266 | Afamelanotide | TFC | TFC-2502-Y6610 | 2025-Q1 | 98.58 | 4.81 | — | Laboratory-retained | 0 | PASS |